Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anterix (ATEX) Cost of Revenue (2016 - 2025)

Anterix's Cost of Revenue history spans 13 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 9.93% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $6.0 million, down 4.31%, while the annual FY2025 figure was $6.1 million, 7.32% up from the prior year.
  • Cost of Revenue reached $1.4 million in Q4 2025 per ATEX's latest filing, down from $1.4 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $1.9 million in Q1 2023 to a low of -$464000.0 in Q1 2021.
  • Average Cost of Revenue over 5 years is $1.3 million, with a median of $1.4 million recorded in 2024.
  • The largest YoY upside for Cost of Revenue was 92.82% in 2021 against a maximum downside of 179.32% in 2021.
  • A 5-year view of Cost of Revenue shows it stood at $1.3 million in 2021, then rose by 9.66% to $1.4 million in 2022, then dropped by 0.36% to $1.4 million in 2023, then decreased by 5.14% to $1.3 million in 2024, then increased by 9.93% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for ATEX's Cost of Revenue are $1.4 million (Q4 2025), $1.4 million (Q3 2025), and $1.5 million (Q2 2025).